Menu
Back to Journals » International Journal of Nanomedicine » Volume 16
RETRACTED ARTICLE: Inhibition of Circulating Exosomal miRNA-20b-5p Accelerates Diabetic Wound Repair
Received 22 October 2020
Accepted for publication 30 December 2020
Published 14 January 2021 Volume 2021:16 Pages 371—381
DOI https://doi.org/10.2147/IJN.S287875
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Thomas Webster
This paper has been retracted.
Chen K, Yu T, Wang X. Int J Nanomedicine. 2021;16:371–381.
At the authors request, the Editor and Publisher of the journal International Journal of Nanomedicine have retracted the published article.
The corresponding authors informed the journal that approval from the Laboratory Animal Management Committee at Tongji Hospital, Tongji University School of Medicine, was not received prior to performing the animal experiments, despite a statement contrary to this being used in the article. The authors wished to apologize for this oversight and given the situation, the authors no longer have confidence in the normalization of the animal experiment process and corresponding results. To maintain academic standards, the authors requested to retract the article and the Editor and Publisher agreed with this decision.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.